Tuesday, 02 January 2024 12:17 GMT

$1.92 Trillion Artificial Intelligence (AI) In Healthcare Market Trends And Global Long-Term Forecasts, 2026-2040


(MENAFN- GlobeNewsWire - Nasdaq) AI in healthcare presents significant opportunities to enhance diagnostic accuracy, personalize treatment, and improve patient management through predictive analytics and precision medicine. Key drivers include chronic disease prevalence, aging populations, vast health data, and technological advancements, pushing toward efficiency and preventive care.

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Healthcare Market, till 2040: Distribution by Type of Platform, Type of Component, Type of Application, Type of Technology, End User, Key Geographical Regions and Leading Players: Industry Trends and Global Forecasts" report has been added to ResearchAndMarkets's offering.
The global AI in healthcare market size is estimated to grow from USD 48.5 billion in the current year to USD 1.92 trillion by 2040, at a CAGR of 30% during the forecast period, till 2040. The new study provides market size, growth scenarios, industry trends and future forecasts.
Artificial intelligence is rapidly reshaping healthcare by improving how diseases are detected, treated, and managed across care settings. It enables clinicians to work more efficiently while offering patients safer, more personalized care. AI systems can analyze vast volumes of medical data, such as images, lab values, and electronic health records, to identify subtle patterns that may signal early disease.

In radiology, pathology, cardiology, and oncology, algorithms support clinicians by enhancing diagnostic accuracy and reducing the risk of human error. Beyond diagnosis, AI helps design tailored treatment plans, predict disease progression, and optimize drug selection, supporting the broader move toward precision medicine.
Operationally, AI streamlines workflows through automated clinical documentation, virtual assistants, and decision-support tools embedded in hospital information systems. These applications reduce administrative burden, allowing healthcare professionals to focus more on direct patient interaction and complex decision-making.

At the same time, remote patient monitoring powered by AI-enabled wearables supports continuous tracking of vital signs and early detection of complications, shifting healthcare from reactive to preventive models. Considering the above mentioned factors, the AI in healthcare market is expected to grow significantly throughout the forecast period.
Transformative Role of Artificial Intelligence in Remote Monitoring and Personalized Medicine
Artificial Intelligence (AI) enhances remote patient monitoring (RPM) and personalized medicine by enabling continuous, data-driven care delivery. Wearable devices and home sensors track vital signs, including heart rate, blood pressure, oxygen saturation, and glucose levels in real time. AI algorithms detect subtle anomalies, such as irregular cardiac rhythms or declining oxygenation, triggering timely alerts to clinicians and facilitating early interventions. This optimizes management of chronic conditions like diabetes, cardiovascular disease, and chronic obstructive pulmonary disease (COPD) in outpatient settings.
In personalized medicine, AI integrates individual genomic profiles, lifestyle factors, and historical health data to develop tailored treatment strategies, forecast therapeutic responses, and dynamically adjust dosages or regimens. Collectively, these capabilities reduce healthcare costs, expand access, and facilitate home-based models.
Key Drivers Propelling Growth of AI in Healthcare Market
The growth of artificial intelligence (AI) in healthcare is being driven by several key factors including the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions along with a globally aging population. This generates substantial demand for advanced diagnostic and management solutions. The proliferation of vast health datasets from electronic health records, wearables, and diagnostic tests enables AI to enhance predictive analytics, diagnostics, and personalized therapies.

Advancements in machine learning algorithms, cost-effective computing infrastructure, and scalable cloud technologies facilitate broader AI adoption. Workforce shortages among clinicians drive automation of routine tasks, cost reductions, and accelerated drug discovery processes. Substantial venture capital and corporate investments further fuels innovation and growth within this market.
AI in Healthcare Evolution: Emerging Trends in the Industry
Emerging trends in artificial intelligence (AI) for healthcare include advanced wearable devices that enable real-time health monitoring and proactive clinician alerts for anomalies such as arrhythmias. Generative AI facilitates automated clinical documentation, synthetic patient data generation for secure model training, and accelerated drug discovery pipelines. Further, autonomous AI agents function as virtual assistants, streamlining appointment scheduling and post-care follow-up.

Enhanced diagnostics leverage AI for rapid detection of malignancies and cerebrovascular events in imaging. complemented by precision medicine that customizes therapies based on genomic and lifestyle profiles. Predictive analytics mitigates risks like sepsis through early warnings, while expanded remote care integrates AI-driven chatbots and virtual nursing, optimizing efficiency, cost-effectiveness, and global accessibility. These advancements collectively position AI as a cornerstone of next-generation healthcare, driving transformative improvements in patient outcomes, operational efficiency, and equitable access worldwide.
Key Market Challenges
The AI in healthcare market faces several critical challenges that hinder its full-scale adoption. These include data quality issues, with healthcare datasets frequently fragmented, incomplete, which complicates accurate model training. Privacy and cybersecurity vulnerabilities are also prominent, as patient data demands stringent protection against breaches.

Further, high implementation costs, regulatory ambiguity, and ethical concerns over accountability foster reluctance among clinicians and institutions. To overcome these issues, the industry needs better data standards, skilled professionals, and strong policies to unlock the full potential of AI in healthcare.

Key Questions Answered in this Report

  • What is the current and future market size?
  • Who are the leading companies in this market?
  • What are the growth drivers that are likely to influence the evolution of this market?
  • What are the key partnership and funding trends shaping this industry?
  • Which region is likely to grow at higher CAGR till 2040?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Company Profiles

  • Google
    • Company Overview
    • Company Mission
    • Company Footprint
    • Management Team
    • Contact Details
    • Financial Performance
    • Operating Business Segments
    • Technology / Platform Portfolio
    • MOAT Analysis
    • Recent Developments and Future Outlook
  • GE Healthcare
  • IBM
  • Intel
  • Itrex
  • IQVIA
  • Microsoft
  • Medtronic
  • Medidata
  • Merck
  • NVIDIA
  • Oracle

AI in Healthcare Market: Key Market Segmentation

Type of Platform

  • Solutions
  • Services

Type of Component

  • Hardware
  • Software Solution
  • Services
  • Others

Type of Application

  • Robot-Assisted Surgery
  • Virtual Assistants
  • Administrative Workflow Assistants
  • Connected Medical Devices
  • Medical Imaging & Diagnostics
  • Clinical Trials
  • Fraud Detection
  • Cybersecurity
  • Dosage Error Reduction
  • Precision Medicine
  • Drug Discovery & Development
  • Lifestyle Management & Remote Patient Monitoring Wearables
  • Other Applications

Type of Technology

  • Machine Learning
  • Natural Language Processing
  • Context-aware Computing
  • Computer Vision

End User

  • Healthcare Providers
  • Healthcare Payers
  • Healthcare Companies
  • Patients
  • Other End Users

Geographical Regions

  • North America
  • US
  • Canada
  • Mexico
  • Other North American countries
  • Europe
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • UK
  • Other European countries
  • Asia
  • China
  • India
  • Japan
  • Singapore
  • South Korea
  • Other Asian countries
  • Latin America
  • Brazil
  • Chile
  • Colombia
  • Venezuela
  • Other Latin American countries
  • Middle East and North Africa
  • Egypt
  • Iran
  • Iraq
  • Israel
  • Kuwait
  • Saudi Arabia
  • UAE
  • Other MENA countries
  • Rest of the World
  • Australia
  • New Zealand
  • Other countries

Additional Benefits

  • Complimentary Dynamic Excel Dashboards for Analytical Modules
  • Exclusive 15% Free Content Customization
  • Personalized Interactive Report Walkthrough with the Research Team
  • Free Report Updates for Versions Older than 6-12 Months

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN03032026004107003653ID1110811272



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search